Whole Shine Medical Technology Balance Sheet Health
Financial Health criteria checks 4/6
Whole Shine Medical Technology has a total shareholder equity of CN¥492.4M and total debt of CN¥335.0M, which brings its debt-to-equity ratio to 68%. Its total assets and total liabilities are CN¥1.6B and CN¥1.1B respectively. Whole Shine Medical Technology's EBIT is CN¥77.5M making its interest coverage ratio 2.6. It has cash and short-term investments of CN¥154.8M.
Key information
68.0%
Debt to equity ratio
CN¥334.98m
Debt
| Interest coverage ratio | 2.6x |
| Cash | CN¥154.84m |
| Equity | CN¥492.42m |
| Total liabilities | CN¥1.07b |
| Total assets | CN¥1.57b |
Recent financial health updates
No updates
Recent updates
Further Upside For Whole Shine Medical Technology Co., Ltd. (SZSE:002622) Shares Could Introduce Price Risks After 36% Bounce
Oct 01
Whole Shine Medical Technology (SZSE:002622) Is Experiencing Growth In Returns On Capital
Aug 26Whole Shine Medical Technology Co., Ltd. (SZSE:002622) Stock's 27% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Jul 21Not Many Are Piling Into Whole Shine Medical Technology Co., Ltd. (SZSE:002622) Stock Yet As It Plummets 27%
Jun 05Why We're Not Concerned Yet About Whole Shine Medical Technology Co., Ltd.'s (SZSE:002622) 28% Share Price Plunge
Apr 21Shareholders Should Be Pleased With Whole Shine Medical Technology Co., Ltd.'s (SZSE:002622) Price
Mar 05Financial Position Analysis
Short Term Liabilities: 002622's short term assets (CN¥313.0M) do not cover its short term liabilities (CN¥893.3M).
Long Term Liabilities: 002622's short term assets (CN¥313.0M) exceed its long term liabilities (CN¥180.0M).
Debt to Equity History and Analysis
Debt Level: 002622's net debt to equity ratio (36.6%) is considered satisfactory.
Reducing Debt: 002622's debt to equity ratio has increased from 31.4% to 68% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 002622 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 002622 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 30% per year.